219 related articles for article (PubMed ID: 24508260)
1. miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
Fu J; Xu X; Kang L; Zhou L; Wang S; Lu J; Cheng L; Fan Z; Yuan B; Tian P; Zheng X; Yu C; Ye Q; Lv Z
Biochem Biophys Res Commun; 2014 Mar; 445(2):314-9. PubMed ID: 24508260
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2.
Yuan Y; Zheng S; Li Q; Xiang X; Gao T; Ran P; Sun L; Huang Q; Xie F; Du J; Xiao C
Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):220-8. PubMed ID: 26837415
[TBL] [Abstract][Full Text] [Related]
3. The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.
Liang Y; Xu X; Wang T; Li Y; You W; Fu J; Liu Y; Jin S; Ji Q; Zhao W; Song Q; Li L; Hong T; Huang J; Lyu Z; Ye Q
Cell Death Dis; 2017 Jul; 8(7):e2928. PubMed ID: 28703807
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration.
Xiong J; Wei B; Ye Q; Liu W
Biochem Biophys Res Commun; 2019 Aug; 516(3):1013-1018. PubMed ID: 27003255
[TBL] [Abstract][Full Text] [Related]
6. Aberrant hypomethylation and overexpression of the eyes absent homologue 2 suppresses tumor cell growth of human lung adenocarcinoma cells.
Gao T; Zheng S; Li Q; Ran P; Sun L; Yuan Y; Xiao C
Oncol Rep; 2015 Nov; 34(5):2333-42. PubMed ID: 26329363
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
[TBL] [Abstract][Full Text] [Related]
8. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G
Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356
[TBL] [Abstract][Full Text] [Related]
9. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
10. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
11. miR-219a-5p represses migration and invasion of osteosarcoma cells via targeting EYA2.
Zhu X; Chen L; Lin J
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1004-S1010. PubMed ID: 30449183
[TBL] [Abstract][Full Text] [Related]
12. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
Cui W; Zhang S; Shan C; Zhou L; Zhou Z
FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
[TBL] [Abstract][Full Text] [Related]
13. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
Qiu T; Zhou X; Wang J; Du Y; Xu J; Huang Z; Zhu W; Shu Y; Liu P
FEBS Lett; 2014 Apr; 588(7):1168-77. PubMed ID: 24613927
[TBL] [Abstract][Full Text] [Related]
14. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells.
Flores-Pérez A; Marchat LA; Rodríguez-Cuevas S; Bautista VP; Fuentes-Mera L; Romero-Zamora D; Maciel-Dominguez A; de la Cruz OH; Fonseca-Sánchez M; Ruíz-García E; la Vega HA; López-Camarillo C
BMC Cancer; 2016 Jul; 16():379. PubMed ID: 27377268
[TBL] [Abstract][Full Text] [Related]
17. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
18. Eya2 overexpression promotes the invasion of human astrocytoma through the regulation of ERK/MMP9 signaling.
Wen Z; Liang C; Pan Q; Wang Y
Int J Mol Med; 2017 Nov; 40(5):1315-1322. PubMed ID: 28901379
[TBL] [Abstract][Full Text] [Related]
19. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
[TBL] [Abstract][Full Text] [Related]
20. miR-145 inhibits breast cancer cell growth through RTKN.
Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]